Can Primary Aldosteronism Cause Fatigue, Anxiety, Brain Fog?
At a Glance
Primary aldosteronism can contribute to fatigue, anxiety, and brain fog, especially when low potassium, poor sleep, or blood pressure changes are present. Treatment often improves quality of life, but persistent symptoms should be checked for other causes.
In this answer
3 sections
Primary aldosteronism (PA) can be associated with non-cardiovascular symptoms like severe fatigue, anxiety, mood changes, and cognitive issues—often described by patients as “brain fog.” While healthcare providers often focus on how PA affects your blood pressure and heart, research shows that excess aldosterone is also linked to a lower physical and mental quality of life in some people [1]. However, because fatigue and brain fog are non-specific and have many potential causes (like thyroid disease, menopause, or depression), it is important to evaluate all possibilities rather than assuming PA is the only cause.
Proposed Links to the Brain
Researchers are still studying exactly how aldosterone interacts with the central nervous system. We know that specialized proteins called mineralocorticoid receptors are located in brain regions involved in memory and emotional regulation [2].
In experimental studies, constantly high levels of aldosterone have been linked to inflammatory signals and oxidative stress (chemical imbalances) in blood vessels [3][4]. Additionally, some observational imaging studies have found early microstructural changes in the brain’s white matter in people with PA [5]. While these findings suggest possible pathways for how excess aldosterone might affect mood and thinking, they are considered preliminary. Imaging findings do not always directly translate to a person’s daily symptoms.
Understanding Your Symptoms
If you are experiencing systemic symptoms, studies highlight several areas where hyperaldosteronism may contribute to your daily life:
- Cognitive Issues (Brain Fog): Some studies report an association between high aldosterone and lower scores on tests measuring memory and attention [6]. However, cognitive issues can also be heavily influenced by sleep disturbances, blood pressure changes, or medications, so an individual evaluation is necessary.
- Anxiety and Depression: In observational studies, untreated PA is associated with higher reported rates of anxiety, depression, demoralization, and psychological stress compared to the general population or those with common (essential) hypertension [1].
- Fatigue and Potassium Drops: In some patients, PA causes hypokalemia (low blood potassium), which can lead to muscle weakness, cramping, and severe fatigue [7].
- Sleep Disturbances: People with PA often report poor sleep quality and have a higher rate of obstructive sleep apnea [8][9]. While the two conditions are frequently linked, treating PA does not cure sleep apnea. If you snore loudly or wake up unrefreshed, you may need a separate sleep evaluation.
When to Seek Immediate Help: Severe hypokalemia (very low potassium) is dangerous. Seek immediate emergency medical care if you experience extreme weakness, fainting, chest pain, or irregular heartbeats. Never start potassium supplements or change your medication doses without direct clinician guidance.
Expectations for Treatment
The primary goal of PA treatment is to control aldosterone, lower blood pressure, and protect your long-term health. Quality of life (QoL) studies show that physical and mental well-being often improve after effective PA-specific treatment [1][10]. Correcting low potassium (if present) is also a major factor in improving how you feel [7].
Treatment approaches depend on the underlying subtype of your PA:
- Adrenalectomy (Surgery): If specialized testing shows that only one adrenal gland is overproducing aldosterone (unilateral PA), surgical removal of that gland is often recommended and can significantly improve QoL [11].
- Medication: If both glands are overactive (bilateral PA) or surgery is not an option, you will likely be treated with mineralocorticoid receptor antagonists (MRAs, such as spironolactone or eplerenone) [10]. MRAs block the effects of aldosterone but require ongoing monitoring for kidney function and the risk of high potassium.
While many patients experience relief from fatigue and anxiety after treatment, improvement can vary. Treating PA does not guarantee the resolution of all cognitive or mood symptoms [10]. If symptoms like brain fog or sleep issues persist after your blood pressure and potassium have normalized, it is important to work with your doctor to explore other potential causes rather than assuming your PA treatment is failing.
Common questions in this guide
Could primary aldosteronism explain my fatigue, anxiety, or brain fog?
How does low potassium affect people with primary aldosteronism?
Will treating primary aldosteronism make brain fog and fatigue go away?
Can primary aldosteronism affect sleep or cause sleep apnea?
What treatments are used when primary aldosteronism causes symptoms?
Related questions
Show more
Get notified when new evidence is published on hyperaldosteronism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review.
Velema MS, de Nooijer AH, Burgers VWG, et al.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2017; (49(12)):943-950 doi:10.1055/s-0043-121706.
PMID: 29202493 - 2
Aldosterone in the brain and cognition: knowns and unknowns.
Nieckarz A, Graff B, Burnier M, et al.
Frontiers in endocrinology 2024; (15()):1456211 doi:10.3389/fendo.2024.1456211.
PMID: 39553314 - 3
Aldosterone, the brain, and the blood pressure ceiling: a neurological case for aldosterone synthase inhibitors in resistant hypertension.
Cancelloni V, Caso V
American journal of hypertension 2026; (39(Supplement_1)):S57-S65 doi:10.1093/ajh/hpag091.
PMID: 42847220 - 4
Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.
Dinh QN, Young MJ, Evans MA, et al.
Brain research 2016; (1637()):146-153 doi:10.1016/j.brainres.2016.02.034.
PMID: 26923165 - 5
Alterations of White Matter Microstructure in Primary Aldosteronism Patients With Normal Cognitive Functioning Using Diffusion Tensor Imaging.
Chen W, Deng S, Li H, et al.
International journal of general medicine 2025; (18()):1089-1102 doi:10.2147/IJGM.S499346.
PMID: 40026812 - 6
Primary Aldosteronism and Cognitive Dysfunction: A Case-Control Study.
Herceg J, Vukorepa G, Karanović Štambuk S
Journal of clinical medicine 2025; (14(13)) doi:10.3390/jcm14134618.
PMID: 40648993 - 7
A Prospective Observational Study of Factors Affecting the Change in Quality of Life in Patients With Primary Aldosteronism After Treatment.
Yu J, Xu B, Ma G, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2024; (30(1)):19-24 doi:10.1016/j.eprac.2023.10.003.
PMID: 37858723 - 8
Sleep disturbances in primary aldosteronism are associated to depressive symptoms - Could specific mineralocorticoidreceptors be a common pathway?
Adolf C, Murck H, Sarkis AL, et al.
Journal of psychiatric research 2024; (172()):66-70 doi:10.1016/j.jpsychires.2024.01.042.
PMID: 38367319 - 9
Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
Wang E, Chomsky-Higgins K, Chen Y, et al.
The Journal of surgical research 2019; (236()):37-43 doi:10.1016/j.jss.2018.10.040.
PMID: 30694777 - 10
Quality of life in primary aldosteronism, medical vs surgical treatment: a systematic review and meta-analysis.
Wever M, Basile C, Bobbio E, et al.
Journal of endocrinological investigation 2026; (49(9)):2305-2313 doi:10.1007/s40618-026-02903-6.
PMID: 42090114 - 11
Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment.
Velema M, Dekkers T, Hermus A, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(1)):16-24 doi:10.1210/jc.2017-01442.
PMID: 29099925
This page is for informational purposes only and does not constitute medical advice. A clinician should assess your symptoms, potassium levels, sleep, and treatment options in light of your overall health.